PLMA_1170x120_10-8-21

Issues

Deadline for Rx transaction data on horizon

Deadline for Rx transaction data on horizon

With the exception of wartime, concerns about the supply chain have never in living memory been more pressing than they are today. Americans, long accustomed to quick, easy access to relatively low-priced goods, have been confronted with a unusually high number of out-of-stocks since the arrival of COVID-19 and, based on the number of container

White House spends $1 billion to boost COVID testing

White House spends $1 billion to boost COVID testing

NEW YORK — In an effort to keep reining in the pandemic, the Biden administration will invest $1 billion to quadruple the national supply of at-home COVID-19 tests by December. In addition, it is expanding the number of free community-based test sites to 30,000 nationwide, including 20,000 in pharmacies. The White House’s announcement of the

Walgreens ensuring that it’s a step ahead of the flu

Walgreens ensuring that it’s a step ahead of the flu

DEERFIELD, Ill. — Many medical experts report that, when it comes to the flu, the last couple of seasons have been significantly lower in number of cases thanks to COVID-19 safety measures, such as masking up, social distancing and lockdowns. Now some medical and health experts are saying that there is a lot of uncertainty

Pharmacy Roundtable: The challenges and rewards of a seminal time

Pharmacy Roundtable: The challenges and rewards of a seminal time

The pandemic has brought — in addition to peril — promise for pharmacy operators who have become central to testing and vaccination efforts. The impact of the crisis on pharmacy’s present and future, among other topics, was explored during a Chain Drug Review roundtable held virtually in conjunction with the NACDS Total Store Expo. Woldt:

Talent is scarce; recruiting it requires adaptation

Talent is scarce; recruiting it requires adaptation

If talent acquisition and retention isn’t a top-five topic for your executive team, it should be. The reason is straightforward: The U.S. labor market has undergone significant changes, resulting in fewer available workers and more open jobs — 10.9 million — than at any time since that statistic has been measured. As if that weren’t

Coming soon to a pharmacy near you: Biosimilars

Coming soon to a pharmacy near you: Biosimilars

Working at the forefront of health care, pharmacists have seen myriad transformations of the prescription medicines landscape. And they are about to see another new development: biosimilars dispensed at the pharmacy. The expanded availability of biosimilars will also change the role of pharmacists, increasing their ability to help patients access more-affordable treatments. Currently, biologic therapies

Fulfilling interchangeables’ promise will take work

Fulfilling interchangeables’ promise will take work

Pharmacy-substitutable biologics, known as interchangeables, have long been little more than an idea. Since the Biologics Price Competition and Innovation Act of 2009 (BPCIA) created a dual pathway for follow-on biologics — with biosimilars that are prescribed by name by a health care provider and interchangeables that can be automatically substituted at the pharmacy —

Here’s how to retain consumers gained during COVID

Here’s how to retain consumers gained during COVID

One of the most positive stories to come out of the pandemic is the pivotal role that retail pharmacies played in the vaccination effort and how it helped the country gain control over the spread of COVID 19. While chain drug had already contributed to the response effort before the vaccinations with COVID-19 testing, drug

Video Forum: Wendy Liebmann, WSL Strategic Retail

Video Forum: Wendy Liebmann, WSL Strategic Retail

Wendy Liebmann has devoted her career to charting the changing wants and needs of consumers and analyzing what that evolution means for the retail and CPG sectors. In this week’s Video Forum, Liebmann, chief executive officer and chief shopper at WSL Strategic Retail, talks about mass market retailers’ performance during the COVID pandemic, ongoing industrywide

Changes to Medicare Part D threaten savings for seniors

Changes to Medicare Part D threaten savings for seniors

On the tiering issue for generics, answering the question: “Why are your Part D patients paying higher co-pays for low-cost generics?” The availability of generic drugs has long meant safe, effective and affordable access to medicines for America’s patients. Generics are an integral component of patient care, offering quality, lower-cost versions of prescription drugs approved

1 2 3 242